Balyasny Asset Management LLC Eli Lilly & CO Transaction History

Balyasny Asset Management LLC

$54.8 Billion
Q1 2024

A detailed history of Balyasny Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Balyasny Asset Management LLC holds 2,200 shares of LLY stock, worth $1.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,200

Previous 109,057 97.98%

Holding current value

$1.99 Million

Previous $63.6 Million 97.31%

% of portfolio

0.0%

Previous 0.12%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $20.3 Million - $27.1 Million	-34,262 Reduced 31.42%	74,795 $58.2 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $55 Million - $64.9 Million	104,797 Added 2460.02%	109,057 $63.6 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $1.85 Million - $2.55 Million	4,260 New	4,260 $2.29 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $25.3 Million - $29.7 Million	81,358 Added 7733.65%	82,410 $28.3 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $40 Million - $46.6 Million	-124,293 Reduced 99.16%	1,052 $384,000

Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $105 Million - $120 Million	-354,506 Reduced 73.88%	125,345 $40.5 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $134 Million - $157 Million	479,851 New	479,851 $156 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $24.4 Million - $30.3 Million	-103,994 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $17.1 Million - $21.3 Million	76,251 Added 274.85%	103,994 $28.7 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $6.15 Million - $7.57 Million	27,743 New	27,743 $6.41 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $51 Million - $66 Million	-310,461 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $11.8 Million - $15.6 Million	90,341 Added 41.04%	310,461 $52.4 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $32.2 Million - $37.2 Million	220,120 New	220,120 $32.6 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $46.5 Million - $57.5 Million	-390,482 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $41.3 Million - $51.2 Million	386,680 Added 10170.44%	390,482 $51.3 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $1.47 Million - $1.6 Million	-13,754 Reduced 78.34%	3,802 $425,000
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $1.5 Million - $1.76 Million	-13,577 Reduced 43.61%	17,556 $1.95 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $50.4 Million - $59.3 Million	-452,947 Reduced 93.57%	31,133 $4.04 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $43.4 Million - $48.6 Million	409,932 Added 552.86%	484,080 $56 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $5.77 Million - $7.22 Million	67,240 Added 973.36%	74,148 $7.96 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $10.3 Million - $11.9 Million	-136,611 Reduced 95.19%	6,908 $589,000
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $1.59 Million - $1.88 Million	21,457 Added 17.58%	143,519 $11.1 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $1.16 Million - $1.24 Million	14,105 Added 13.07%	122,062 $10.3 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $8.32 Million - $9.23 Million	107,957	107,957 $9.24 Million

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Eli Lilly & CO Transaction History